Answers are grounded in this paper and cite their sources.
We describe 2 adult patients with acute lymphoblastic leukaemia (ALL) who died from pulmonary embolism following L-asparaginase treatment. Since this drug is known to cause a decrease in antithrombin III, the most important protein physiologically involved in the neutralization of thrombin, we studied the behaviour of this inhibitor in 14 ALL patients treated with a protocol including a 14-day course of L-asparaginase. A significant but transient fall of biological and immunological antithrombin III and a concomitant reduction of fibrinogen were documented.
No takes yet. Share an insight, caveat, or question.
Barbui et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: